Your browser doesn't support javascript.
loading
PSMA-617 inhibits proliferation and potentiates the 177Lu-PSMA-617-induced death of human prostate cancer cells.
Zhao, Yi; Culman, Juraj; Cascorbi, Ingolf; Nithack, Niklas; Marx, Marlies; Zuhayra, Maaz; Lützen, Ulf.
Afiliação
  • Zhao Y; Department of Nuclear Medicine, Molecular Imaging, Diagnostics and Therapy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. Yi.Zhao@uksh.de.
  • Culman J; Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Cascorbi I; Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Nithack N; Central Rhine Community Hospital-Clinic for Urology and Pediatric Urology, Koblenz, Germany.
  • Marx M; Department of Nuclear Medicine, Molecular Imaging, Diagnostics and Therapy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Zuhayra M; Department of Nuclear Medicine, Molecular Imaging, Diagnostics and Therapy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Lützen U; Department of Nuclear Medicine, Molecular Imaging, Diagnostics and Therapy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Naunyn Schmiedebergs Arch Pharmacol ; 396(11): 3315-3326, 2023 11.
Article em En | MEDLINE | ID: mdl-37284895

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article